TY - JOUR
T1 - Vertrouwen van Turkse en Arabische allochtonen in hun oncoloog
AU - Hillen, Marij A.
AU - El Temna, Shaima
AU - van der Vloodt, Jane
AU - de Haes, Hanneke C. J. M.
AU - Smets, Ellen M. A.
PY - 2013
Y1 - 2013
N2 - To examine the nature of the trust that Turkish and Arabic ethnic minority patients suffering from cancer have in their oncologist, and to explore how this trust is established. We interviewed 9 cancer patients with Turkish and Arabic backgrounds about the trust they have in their oncologist. Semi-structured qualitative interviews. We interviewed 9 cancer patients with Turkish and Arabic backgrounds about the trust they have in their oncologist. The trust that these patients have in their oncologist seemed to evolve gradually over time. According to the patients, three specific elements seemed to promote trust. Firstly, patients attached importance to a strongly proactive physician approach, even in the palliative phase when treatment was no longer indicated. A wait-and-see attitude was perceived by patients as a lack of willingness to help, and was detrimental to their trust. Secondly, patients indicated that they needed their oncologist to reassure them and avoided discussing depressing topics, so that they would not give up hope. Finally, the oncologist's non-verbal communication, particularly his or her facial expression, contributed to patients' trust. Among these Turkish and Arabic ethnic minority cancer patients, trust in the physician appeared not to be self-evident, and might to some extent need to be 'earned' by oncologists. Because of these patients' great need for a proactive attitude, it is desirable that oncologists clearly explain their motivation when choosing for a possibly less active approach. In order to preserve hope, it is important that oncologists discover exactly what their patients' information needs are. The results of this explorative, small-scale study may help physicians to optimise the trust that Turkish and Arabic ethnic minority patients have in them
AB - To examine the nature of the trust that Turkish and Arabic ethnic minority patients suffering from cancer have in their oncologist, and to explore how this trust is established. We interviewed 9 cancer patients with Turkish and Arabic backgrounds about the trust they have in their oncologist. Semi-structured qualitative interviews. We interviewed 9 cancer patients with Turkish and Arabic backgrounds about the trust they have in their oncologist. The trust that these patients have in their oncologist seemed to evolve gradually over time. According to the patients, three specific elements seemed to promote trust. Firstly, patients attached importance to a strongly proactive physician approach, even in the palliative phase when treatment was no longer indicated. A wait-and-see attitude was perceived by patients as a lack of willingness to help, and was detrimental to their trust. Secondly, patients indicated that they needed their oncologist to reassure them and avoided discussing depressing topics, so that they would not give up hope. Finally, the oncologist's non-verbal communication, particularly his or her facial expression, contributed to patients' trust. Among these Turkish and Arabic ethnic minority cancer patients, trust in the physician appeared not to be self-evident, and might to some extent need to be 'earned' by oncologists. Because of these patients' great need for a proactive attitude, it is desirable that oncologists clearly explain their motivation when choosing for a possibly less active approach. In order to preserve hope, it is important that oncologists discover exactly what their patients' information needs are. The results of this explorative, small-scale study may help physicians to optimise the trust that Turkish and Arabic ethnic minority patients have in them
UR - https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=84877856984&origin=inward
M3 - Article
C2 - 23594873
SN - 0028-2162
VL - 157
SP - A5881
JO - Nederlands Tijdschrift voor Geneeskunde
JF - Nederlands Tijdschrift voor Geneeskunde
IS - 18
M1 - A5881
ER -